KV Settles Promote Innovation False Marking Suit

Law360, New York (October 14, 2010, 3:57 PM EDT) -- KV Pharmaceutical Co. has reached a settlement in a false patent marking suit filed by Promote Innovation LLC over a yeast infection treatment.

Judge T. John Ward of the U.S. District Court for the Eastern District of Texas on Wednesday signed off on a joint stipulation of dismissal the parties filed last week.

Promote Innovation's suit, filed in July, claimed that KV and its subsidiary Ther-Rx Corp. have falsely marked its yeast infection treatment Gynazole-1.

KV has continued to mark Gynazole-1 with U.S. Patent Numbers 4,078,071,...
To view the full article, register now.